Equity · Consumer Defensive
NUS
Nu Skin Enterprises, Inc. · NYSE
The line runs $5.47 on 12 June through $4.74 on 21 August, on a scale from $4.5 to $6.0. Days the market did not trade hold the previous close, flat.
The chart above plots the price of NUS over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 49 sessions over that window: $5.47 on 12 June 2026 through $4.74 on 21 August 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Sep 10, 2026
NUS insider trades
NUS has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 10 June 2026.
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Showing the 12 most recent of 32 compensation filings in this window. The figures above count all of them.
NUS reported financials
NUS reported revenue of $1.5B for the fiscal year ended 31 Dec 2025. Net income over the same period was $160.2M.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
NUS earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
NUS institutional holders
5 of the 45 institutional funds we track reported a NUS position for the quarter ended 30 Jun 2026 — a combined $24.1M; the latest of those filings landed 02 Sep 2026.
Source: SEC EDGAR 13F filings